Venmax Drugs Board Meeting on Aug 7 to Approve Q1 FY27 Unaudited Results

Venmax Drugs and Pharmaceuticals Ltd has announced that its Board of Directors will convene on August 7, 2026. The primary agenda items include the consideration and approval of the Unaudited Financial Results for the quarter ended June 30, 2026. Additionally, the board will discuss and approve the forfeiture of partly paid-up share warrants. The trading window for designated persons, which commenced on July 1, 2026, will remain closed until August 9, 2026, extending 48 hours beyond the approval of the financial results.